Insulin resistance as a common clinical feature in diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerosis deserves more attention in COVID-19
Enregistré dans:
Auteur principal: | Abdolkarim Mahrooz |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wolters Kluwer Medknow Publications
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ab16a58aeeeb4dcba6f3a950d6bb94b1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Hyperosmolarity Deserves More Attention in Critically Ill COVID-19 Patients with Diabetes: A Cohort-Based Study
par: Gou L, et autres
Publié: (2021) -
Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
par: Marcela Doktorova, et autres
Publié: (2017) -
ABCC6 deficiency promotes dyslipidemia and atherosclerosis
par: Christopher Brampton, et autres
Publié: (2021) -
Maternal obesity in Africa: Is it time to pay more attention?
par: O.J. Onubi, et autres
Publié: (2015) -
TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis
par: Daniel Zysset, et autres
Publié: (2016)